Back
Beam Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
BEAM
Sponsored
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
28
BEAM
Beam Therapeutics
Last Price:
21.76
Seasonality Move:
25.98%
7 Day Trial
ALL ACCESS PASS
$
7
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" projectBeam Therapeutics Price Quote
$21.76
+0.02 (+2.54%)
(Updated: May 2, 2024 at 5:53 AM ET)
Beam Therapeutics Key Stats
Sell
28
Beam Therapeutics (BEAM)
is a Sell
Day range:
$21.01 - $22.83
52-week range:
$16.95 - $49.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.44
P/B ratio:
1.81%
Volume:
1.3M
Avg. volume:
1.4M
1-year change:
-29.25%
Market cap:
$1.8B
Revenue:
$377.7M
EPS:
$-1.9
How Much Does Beam Therapeutics Make?
-
How Much Are Beam Therapeutics's Sales Annually?
BEAM Revenues are $377.7M -
How Much Profit Does Beam Therapeutics's Make A Year?
BEAM net income is -$132.5M
Is Beam Therapeutics Growing As A Company?
-
What Is Beam Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 14.78% -
What Is Beam Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Beam Therapeutics Stock Price Performance
-
Did Beam Therapeutics Stock Go Up Last Month?
Beam Therapeutics share price went down by -33.44% last month -
Did BEAM's Share Price Rise Over The Last Year?
BEAM share price fell by -29.25% over the past 1 year
What Is Beam Therapeutics 52-Week High & Low?
-
What Is Beam Therapeutics’s 52-Week High Share Price?
Beam Therapeutics has traded as high as $49.50 over the past 52 weeks -
What Is Beam Therapeutics’s 52-Week Low Share Price?
Beam Therapeutics has traded as low as $16.95 over the past 52 weeks
Beam Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Beam Therapeutics?
-
How Much Debt Does Beam Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Beam Therapeutics Have?
Cash and short term investments quarterly total is $1.2B -
What Is Beam Therapeutics’s Book Value Per Share?
Book value per share is 12.02
Is Beam Therapeutics Cash Flow Positive?
-
What Is BEAM Cash Flow From Operations?
Cash flow from operations (TTM) is -$149.2M -
What Is Beam Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $276.4M -
What Is Beam Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $71.8M
Beam Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
BEAM return on invested capital is -16.29% -
What Is Beam Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -9.78% -
What Is BEAM Return On Equity?
ROE is a measure of profitability and is -16.29%
Beam Therapeutics Earnings Date & Stock Price
-
What Is Beam Therapeutics's Stock Price Today?
A single share of BEAM can be purchased today for 21.74 -
What Is Beam Therapeutics’s Stock Symbol?
Beam Therapeutics trades on the nasdaq under the ticker symbol: BEAM -
When Is Beam Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Beam Therapeutics is scheduled on May 10, 2024 -
When Is BEAM's next ex-dividend date?
Beam Therapeutics's next ex-dividend date is May 7, 2020 -
How To Buy Beam Therapeutics Stock?
You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Beam Therapeutics Competitors
-
Who Are Beam Therapeutics's Competitors?
Below is a list of companies who compete with Beam Therapeutics or are related in some way:
Beam Therapeutics Dividend Yield
Data Unavailable
Beam Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 343.61% |
Revenue: | 1478.04% | 839.01% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 49.54 |
Upside from Last Price: | 127.87% |